Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response

Olga Aprelikova, Silvia Pandolfi, Sean Tackett, Mark Ferreira, Konstantin Salnikow, Yvona Ward, John I. Risinger, J. Carl Barrett, John Niederhuber

Research output: Contribution to journalArticle

Abstract

Activation of hypoxia-inducible factors (HIF), responsible for tumor angiogenesis and glycolytic switch, is regulated by reduced oxygen availability. Normally, HIF-α proteins are maintained at low levels, controlled by site-specific hydroxylation carried out by HIF prolyl hydroxylases (PHD) and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitin ligase. Using a yeast two-hybrid screen, we identified an interaction between melanoma antigen-11 (MAGE-11) cancer-testis antigen and the major HIF-α hydroxylating enzyme PHD2. The interaction was confirmed by a pull-down assay, coimmunoprecipitation, and colocalization in both normoxic and hypoxic conditions. Furthermore, MAGE-9, the closest homologue of MAGE-11, was also found to interact with PHD2. MAGE-11 inhibited PHD activity without affecting protein levels. This inhibition was accompanied by stabilization of ectopic or endogenous HIF-1α protein. Knockdown of MAGE-11 by small interfering RNA results in decreased hypoxic induction of HIF-1α and its target genes. Inhibition of PHD by MAGE-11, and following activation of HIFs, is a novel tumor-associated HIF regulatory mechanism. This finding provides new insights into the significance of MAGE expression in tumors and may provide valuable tools for therapeutic intervention because of the restricted expression of the MAGE gene family in cancers, but not in normal tissues.

Original languageEnglish (US)
Pages (from-to)616-624
Number of pages9
JournalCancer Research
Volume69
Issue number2
DOIs
StatePublished - Jan 15 2009
Externally publishedYes

Fingerprint

Hypoxia-Inducible Factor-Proline Dioxygenases
Melanoma-Specific Antigens
Prolyl Hydroxylases
Hypoxia-Inducible Factor 1
Neoplasms
Proteins
Testicular Neoplasms
Hydroxylation
Ligases
Ubiquitin
Small Interfering RNA
Yeasts
Oxygen
Gene Expression
Antigens
Hypoxia
Enzymes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. / Aprelikova, Olga; Pandolfi, Silvia; Tackett, Sean; Ferreira, Mark; Salnikow, Konstantin; Ward, Yvona; Risinger, John I.; Barrett, J. Carl; Niederhuber, John.

In: Cancer Research, Vol. 69, No. 2, 15.01.2009, p. 616-624.

Research output: Contribution to journalArticle

Aprelikova, O, Pandolfi, S, Tackett, S, Ferreira, M, Salnikow, K, Ward, Y, Risinger, JI, Barrett, JC & Niederhuber, J 2009, 'Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response', Cancer Research, vol. 69, no. 2, pp. 616-624. https://doi.org/10.1158/0008-5472.CAN-08-0811
Aprelikova, Olga ; Pandolfi, Silvia ; Tackett, Sean ; Ferreira, Mark ; Salnikow, Konstantin ; Ward, Yvona ; Risinger, John I. ; Barrett, J. Carl ; Niederhuber, John. / Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. In: Cancer Research. 2009 ; Vol. 69, No. 2. pp. 616-624.
@article{259f1ccf0d864eca9d03c29c23e622f5,
title = "Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response",
abstract = "Activation of hypoxia-inducible factors (HIF), responsible for tumor angiogenesis and glycolytic switch, is regulated by reduced oxygen availability. Normally, HIF-α proteins are maintained at low levels, controlled by site-specific hydroxylation carried out by HIF prolyl hydroxylases (PHD) and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitin ligase. Using a yeast two-hybrid screen, we identified an interaction between melanoma antigen-11 (MAGE-11) cancer-testis antigen and the major HIF-α hydroxylating enzyme PHD2. The interaction was confirmed by a pull-down assay, coimmunoprecipitation, and colocalization in both normoxic and hypoxic conditions. Furthermore, MAGE-9, the closest homologue of MAGE-11, was also found to interact with PHD2. MAGE-11 inhibited PHD activity without affecting protein levels. This inhibition was accompanied by stabilization of ectopic or endogenous HIF-1α protein. Knockdown of MAGE-11 by small interfering RNA results in decreased hypoxic induction of HIF-1α and its target genes. Inhibition of PHD by MAGE-11, and following activation of HIFs, is a novel tumor-associated HIF regulatory mechanism. This finding provides new insights into the significance of MAGE expression in tumors and may provide valuable tools for therapeutic intervention because of the restricted expression of the MAGE gene family in cancers, but not in normal tissues.",
author = "Olga Aprelikova and Silvia Pandolfi and Sean Tackett and Mark Ferreira and Konstantin Salnikow and Yvona Ward and Risinger, {John I.} and Barrett, {J. Carl} and John Niederhuber",
year = "2009",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-08-0811",
language = "English (US)",
volume = "69",
pages = "616--624",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response

AU - Aprelikova, Olga

AU - Pandolfi, Silvia

AU - Tackett, Sean

AU - Ferreira, Mark

AU - Salnikow, Konstantin

AU - Ward, Yvona

AU - Risinger, John I.

AU - Barrett, J. Carl

AU - Niederhuber, John

PY - 2009/1/15

Y1 - 2009/1/15

N2 - Activation of hypoxia-inducible factors (HIF), responsible for tumor angiogenesis and glycolytic switch, is regulated by reduced oxygen availability. Normally, HIF-α proteins are maintained at low levels, controlled by site-specific hydroxylation carried out by HIF prolyl hydroxylases (PHD) and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitin ligase. Using a yeast two-hybrid screen, we identified an interaction between melanoma antigen-11 (MAGE-11) cancer-testis antigen and the major HIF-α hydroxylating enzyme PHD2. The interaction was confirmed by a pull-down assay, coimmunoprecipitation, and colocalization in both normoxic and hypoxic conditions. Furthermore, MAGE-9, the closest homologue of MAGE-11, was also found to interact with PHD2. MAGE-11 inhibited PHD activity without affecting protein levels. This inhibition was accompanied by stabilization of ectopic or endogenous HIF-1α protein. Knockdown of MAGE-11 by small interfering RNA results in decreased hypoxic induction of HIF-1α and its target genes. Inhibition of PHD by MAGE-11, and following activation of HIFs, is a novel tumor-associated HIF regulatory mechanism. This finding provides new insights into the significance of MAGE expression in tumors and may provide valuable tools for therapeutic intervention because of the restricted expression of the MAGE gene family in cancers, but not in normal tissues.

AB - Activation of hypoxia-inducible factors (HIF), responsible for tumor angiogenesis and glycolytic switch, is regulated by reduced oxygen availability. Normally, HIF-α proteins are maintained at low levels, controlled by site-specific hydroxylation carried out by HIF prolyl hydroxylases (PHD) and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitin ligase. Using a yeast two-hybrid screen, we identified an interaction between melanoma antigen-11 (MAGE-11) cancer-testis antigen and the major HIF-α hydroxylating enzyme PHD2. The interaction was confirmed by a pull-down assay, coimmunoprecipitation, and colocalization in both normoxic and hypoxic conditions. Furthermore, MAGE-9, the closest homologue of MAGE-11, was also found to interact with PHD2. MAGE-11 inhibited PHD activity without affecting protein levels. This inhibition was accompanied by stabilization of ectopic or endogenous HIF-1α protein. Knockdown of MAGE-11 by small interfering RNA results in decreased hypoxic induction of HIF-1α and its target genes. Inhibition of PHD by MAGE-11, and following activation of HIFs, is a novel tumor-associated HIF regulatory mechanism. This finding provides new insights into the significance of MAGE expression in tumors and may provide valuable tools for therapeutic intervention because of the restricted expression of the MAGE gene family in cancers, but not in normal tissues.

UR - http://www.scopus.com/inward/record.url?scp=58349122490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349122490&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-0811

DO - 10.1158/0008-5472.CAN-08-0811

M3 - Article

C2 - 19147576

AN - SCOPUS:58349122490

VL - 69

SP - 616

EP - 624

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -